

Cytokines levels as an inflammation markers in autoinflammatory diseases
https://doi.org/10.25557/2073-7998.2025.08.48-51
Abstract
Familial Mediterranean fever (FMF) is an autoinflammatory disease manifested by recurrent fever with signs of systemic inflammation caused by MEFV gene pathogenic variants that lead to inflammasome hyperactivation and hyperproduction of IL-1b and IL-18. FMF is a disorder with variable expressivity and penetrance. The study included 1336 samples, 1271 samples were positive for pathogenic variants in MEFV gene. 160 samples divided into 3 groups: 95 patients (FMF) with different MEFV genotypes (5 subgroups), 49 patients with systemic lupus erythematosus (SLE) and 16 samples as a group of healthy donors (HD). Concentrations of CRP, IL-6, IL-8 and IL-18 were measured for all samples. Concentrations of CRP, IL-6 and IL-18 in FMF group was significantly higher than in HD and SLE groups (р < 0.0001). Concentration of IL-18 was significantly higher in all FMF genotypes subgroups than in HD. Comparing IL-18 levels between different pathogenic MEFV variants samples with «aggressive» variants (p.Met694Val and p.Met680Ile) characterized by increased concentration of IL-18 (р = 0.0411).
About the Authors
E. A. DeviatkinaRussian Federation
197101; 6/8, L.Tolstogo st.; St. Petersburg
V. D. Nazarov
Russian Federation
197101; 6/8, L.Tolstogo st.; St. Petersburg
A. K. Musonova
Russian Federation
197101; 6/8, L.Tolstogo st.; St. Petersburg
S. V. Lapin
Russian Federation
197101; 6/8, L.Tolstogo st.; St. Petersburg
I. V. Kholopova
Russian Federation
197101; 6/8, L.Tolstogo st.; St. Petersburg
References
1. Fedorov ES, Salugina SO. Semeynaya sredizemnomorskaya likhoradka (periodicheskaya bolezn’): sovremennyy vzglyad na problemu [Familial Mediterranean fever (periodic disease): history or a real problem]. Sovremennaya Revmatologiya [Modern Rheumatology Journal]. 2018;12(3):61-69. (In Russ.)
2. Ben-Chetrit E., Touitou I. Familial mediterranean Fever in the world. Arthritis Rheum. 2009 Oct 15;61(10):1447-53.
3. Booth D.R., Gillmore J.D., Lachmann H.J., et al. The genetic basis of autosomal dominant familial Mediterranean fever. QJM. 2000;93(4):217-21.
4. Manukyan G., Aminov R. Update on Pyrin Functions and Mechanisms of Familial Mediterranean Fever. Front Microbiol. 2016 31;7:456.
5. Marek-Yagel D., Berkun Y., Padeh S., et al. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum. 2009;60(6):1862-6.
6. Moradian M.M., Sarkisian T., Ajrapetyan H., et al. Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations. J Hum Genet. 2010;55(6):389-93.
7. Ozen S., Bakkaloglu A., Yilmaz E., et al. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol. 2003;30(9):2014-8.
8. Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet. 2001;9(7):473-83.
Review
For citations:
Deviatkina E.A., Nazarov V.D., Musonova A.K., Lapin S.V., Kholopova I.V. Cytokines levels as an inflammation markers in autoinflammatory diseases. Medical Genetics. 2025;24(8):48-51. (In Russ.) https://doi.org/10.25557/2073-7998.2025.08.48-51